News & Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
RESEARCH UPDATES

2025 PGI_Osteoarthritis Pain Model

September 24, 2025
Read More
RESEARCH UPDATES

2025 PGI_Plantar Incision Model of Incisional Pain

September 24, 2025
Read More
RESEARCH UPDATES

Psychogenics is a leading CRO in Clinical Research specializing in preclinical pain models.

September 24, 2025
Read More
PUBLICATION

A systematic assessment of robustness in CNS safety pharmacology.

September 22, 2025
Read More
PUBLICATION

Nutritional supplement containing a nuclear fraction of bovine thymus gland increases the circulating levels of spermidine

September 10, 2025
Read More
RESEARCH UPDATES

Immunohistochemistry (IHC) and Histology Services

July 25, 2025
Read More
RESEARCH UPDATES

MDX mouse model for screening novel therapies for Duchenne Muscular Dystrophy

July 23, 2025
Read More
POSTER

Standardized Spinal Cord Injury Platform for Preclinical Research

June 24, 2025
Read More
RESEARCH UPDATES

Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental condition characterized by challenges in social interaction, communication, and behavior. 

June 24, 2025
Read More